Leon Li is one of the earliest healthcare investor in China. He has more than 20 years of healthcare industry and investment management experience. In 2005, he was responsible for Guobin Health Examination Chain Group’s strategy planning and development.

Mr. Li was the senior investment director in Shanghai Fosun Pharmaceutical Group, and involved in many leading companies investments in health industry. Before this he was the vice president in Ming Yuan Medicare Development Company and senior investment director in Dingfeng Fund. He was responsible and participated in many successful investment cases, including Guobin Health Examination, Shanghai HealthDigit, Ruimei Medical Center of Ruijin Hospital, Chindex, Zhejiang DIAN Diagnostics and Jimin Cancer Hospital.

Mr. Li was the deputy general manager of Guobin Health Examination, executive director of Ruimei Medical Center of Ruijin Hospital, and he was also in charge of Huashan Hospital Health Management Center. He worked in Rx Division of Shanghai Pharmaceuticals as sales vice manager and marketing director.

Education: MBA in Reims Management School in France, Master Degree in Shanghai Tongji University.